Uterine Papillary Serous Carcinoma: Evaluation of Long-Term Survival in Surgically Staged Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Uterine Papillary Serous Carcinoma: Evaluation of Long-Term Survival in Surgically Staged Patients

Published:1998-04 Issue:1 Volume:69 Page:69-73
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Grice Jeffrey,Ek Marit,Greer Benjamin,Koh Wui-Jin,Muntz Howard G.,Cain Joanna,Tamimi Hisham,Stelzer Keith,Figge David,Goff Barbara A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference31 articles.

1. Tubal (serous) carcinoma of the endometrium;Lauchlan;Arch Pathol Lab Med,1981

2. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus;Hendrickson;Gynecol Oncol,1982

3. Papillary carcinomas of the endometrium;Ward;Gynecol Oncol,1990

4. Serous papillary carcinoma of the endometrium: a histopathologic study of 22 cases;Abeler;Gynecol Oncol,1990

5. Papillary serous adenocarcinoma of the endometrium;Jeffrey;Obstet Gynecol,1986

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenocarcinoma of the uterine corpus and sarcomas of the uterus;DiSaia and Creasman Clinical Gynecologic Oncology;2023

2. Malignant diseases of the uterus;Comprehensive Gynecology;2022

3. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis;Gynecologic Oncology;2021-01

4. Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis;Clinical Cancer Research;2020-06-29

5. Endometrial Carcinoma and its Precursors;Advances in Experimental Medicine and Biology;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3